More Clinuvel Pharmaceuticals Limited news
Clinuvel Pharmaceuticals LimitedASX: CUV

Response to ASX price query

Mar 30, 2016 at 2:14 AM EDT · Issued by Clinuvel Pharmaceuticals Limited

Filed with ASX · Mar 30, 2016 at 2:14 AM EDT

On 6ix: 6ix.com/news/response-to-asx-price-query-882

View Attachment

6ix hasn’t read this filing yet.

Clinuvel Pharmaceuticals Limited on 6ix

Earlier from Clinuvel Pharmaceuticals

  • SCENESSE successful in Phase IIa vitiligo studyMar 30, 2016

Later from Clinuvel Pharmaceuticals

  • Clinuvel books European Pre-Submission Meeting for SCENESSEMar 30, 2016
  • Clinuvel completes first Phase II US studyMar 30, 2016
  • Clinuvel granted Australian formulation patentMar 30, 2016
  • Clinuvel presents SCENESSE to global porphyria conferenceMar 30, 2016
  • Clinuvel records first A$1 million in salesMar 30, 2016
All Clinuvel Pharmaceuticals news releases↗

Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.

Follow Clinuvel Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer